Coverage check
For Michigan peptide therapy, “covered” needs a second question.
Which product? For which health condition? Through which pharmacy? Under which part of the plan? Those details can change the answer.
The use can matter as much as the drug.
Medicare
The reason on the prescription matters.
Federal law, as of September 2026, lets Medicare Part D leave out a medicine taken for weight loss.
As of September 2026, the same medicine can be covered by Part D when it is prescribed for a different condition that Medicare recognises, such as diabetes. Even then, that only means it is allowed, and your own plan still decides whether it pays.
The call to the plan
Ask for the rule attached to the exact medicine.
- Does the plan’s drug list include this exact product?
- Does coverage change with the condition being treated?
- Does the plan require prior approval before it pays?
- Must the prescription use a particular pharmacy?
- What will I still owe after the deductible, the copay, or the coinsurance (a share of the price I pay myself)?
- What written notice explains a denial and the appeal path?
Other ways people pay
Cards and health accounts have their own tests.
GLP-1 medicines are the weight-loss and diabetes shots such as Ozempic, Wegovy, Mounjaro and Zepbound. The makers’ savings cards for these drugs, as of September 2026, can be used only with private insurance, like an employer plan, and not with Medicare, Medicaid or military health coverage.
Some people keep money for medical bills in a health savings account (HSA) or a flexible spending account (FSA). As of September 2026, that money can generally cover a prescription drug for a condition a doctor has diagnosed. Something used only for general health does not count.